Menu Close

Summary*

IntelyCare, founded in 2014 and headquartered in Quincy, Massachusetts, is a healthcare talent platform that uses AI technology to match nursing professionals with job opportunities in various care settings. The company offers per diem, contract, full-time, and part-time roles to nursing professionals while serving healthcare organizations as its primary customers.

Since its inception, IntelyCare has demonstrated significant growth and attracted substantial investment. The company has raised a total of $174.3 million across multiple funding rounds, including a Series C round in April 2022 that raised $115 million and valued the company at $1.1 billion. This funding history showcases investor confidence in IntelyCare's business model and potential for future growth.

While there is currently no official news regarding IntelyCare's IPO prospects, the company's strong financial backing and innovative approach to addressing healthcare staffing challenges position it as a notable player in the healthcare technology sector. Factors that could influence any potential IPO decision include market conditions, the company's financial performance, and its strategic growth plans.

IntelyCare operates in a competitive landscape alongside other healthcare staffing platforms such as AMN Healthcare, CareRev, and Clipboard Health. The company's ability to differentiate itself and capture market share in this growing industry may be crucial for its future success and any potential public offering considerations.

Investors interested in the healthcare technology sector may want to keep an eye on IntelyCare's developments, as the company continues to evolve in the dynamic healthcare staffing market. However, it's important to note that any investment decisions should be based on thorough research and consideration of individual financial goals and risk tolerance.

How to invest in IntelyCare

While IntelyCare's IPO prospects remain uncertain, investors eager to gain exposure to innovative healthcare technology companies don't have to wait. At Linqto, we offer members access to interests in pre-IPO private companies, including potential leaders in the healthcare staffing and technology sectors. Our platform allows you to diversify your portfolio with lower minimum investments, potentially benefiting from the growth of emerging industry disruptors like IntelyCare before they go public.

*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.